{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:51:10Z","timestamp":1787032270500,"version":"build-2736575974"},"reference-count":37,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Malignant mesothelioma (MM) is a component of the BAP1 tumor predisposition syndrome. Other than in BAP1 familial studies, nonmesothelial neoplasms in individuals with MM has not been comprehensively assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To assess the spectrum and prevalence of nonmesothelial neoplasms in individuals with MM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Individuals with MM and second neoplasms were identified from a database of 3900 MM cases. The expected prevalence of each type of neoplasm was calculated and compared with the actual prevalence in the study population using available Surveillance, Epidemiology, and End Results data and other published data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Two hundred seventy nonmesothelial neoplasms were identified in 241 individuals (6% of the study population) with MM. Prostate adenocarcinoma was most common. Non-Hodgkin lymphoma, Hodgkin lymphoma, lung carcinoma, urothelial carcinoma, breast carcinoma, chronic lymphocytic leukemia, clear cell renal cell carcinoma, head and neck squamous cell carcinoma, papillary renal cell carcinoma, multiple myeloma\/plasmacytoma, meningioma, pleomorphic undifferentiated sarcoma, chronic myelogenous leukemia, ocular melanoma, hepatocellular carcinoma, liposarcoma, and Wilms tumor all were more prevalent than expected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Nonmesothelial neoplasms are uncommon in individuals with MM, but certain tumor types are increased in prevalence. In an unselected study population with respect to BAP1 status, the prevalence of several tumor types described in BAP1 mutation carriers, including lung carcinoma, clear cell renal cell carcinoma, breast carcinoma, meningioma, pleomorphic undifferentiated sarcoma, and ocular melanoma, was increased.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2017-0307-oa","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T13:41:56Z","timestamp":1520862116000},"page":"730-734","source":"Crossref","is-referenced-by-count":12,"title":["Malignant Mesothelioma in Individuals With Nonmesothelial Neoplasms"],"prefix":"10.5858","volume":"142","author":[{"given":"Kelly J.","family":"Butnor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth N.","family":"Pavlisko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Sporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Roggli","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, University of Vermont, Burlington (Dr Butnor); and the Department of Pathology, Duke University, Durham, North Carolina (Drs Pavlisko, Sporn, and Roggli)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2018,3,12]]},"reference":[{"issue":"3","key":"2020081219330773600_i1543-2165-142-6-730-b01","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2020081219330773600_i1543-2165-142-6-730-b02","article-title":"BAP1 tumor predisposition syndrome","author":"Pilarski","year":"1993","journal-title":"Pagon RA, Adam MP, Ardinger HH, et al, eds. GeneReviews"},{"key":"2020081219330773600_i1543-2165-142-6-730-b03","unstructured":"Online Mendelian Inheritance in Man, OMIM. Baltimore, MD: Johns Hopkins University; 2014."},{"key":"2020081219330773600_i1543-2165-142-6-730-b04","article-title":"Cancer stat fact sheets","author":"Surveillance, Epidemiology, and End Results Program, National Cancer Institute","year":"2017"},{"issue":"3","key":"2020081219330773600_i1543-2165-142-6-730-b05","first-page":"152","article-title":"Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups","volume":"3","author":"Davis","year":"2001","journal-title":"Neuro Oncol"},{"key":"2020081219330773600_i1543-2165-142-6-730-b06","article-title":"St. Jude's Research Hospital Web site","author":"Wilms tumor","year":"2017"},{"key":"2020081219330773600_i1543-2165-142-6-730-b07","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2016.02.007","article-title":"Diffuse malignant mesothelioma and synchronous lung cancer: a clinicopathological study of 18 cases","volume":"95","author":"Butnor","year":"2016","journal-title":"Lung Cancer"},{"key":"2020081219330773600_i1543-2165-142-6-730-b08","first-page":"97","article-title":"Scanning electron microscopic analysis of mineral fibers in human lungs","author":"Roggli","year":"1989","journal-title":"Microprobe Analysis in Medicine"},{"issue":"3","key":"2020081219330773600_i1543-2165-142-6-730-b09","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/01913123.2016.1154633","article-title":"Malignant mesothelioma not related to asbestos exposure: analytical scanning electron microscopic analysis of 83 cases and comparison with 442 asbestos-related cases","volume":"40","author":"Kraynie","year":"2016","journal-title":"Ultrastruct Pathol"},{"issue":"3","key":"2020081219330773600_i1543-2165-142-6-730-b10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/01913123.2016.1170085","article-title":"Asbestos content of lung tissue in patients with malignant peritoneal mesothelioma: a study of 42 cases","volume":"40","author":"de Ridder","year":"2016","journal-title":"Ultrastruct Pathol"},{"issue":"3","key":"2020081219330773600_i1543-2165-142-6-730-b11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.humpath.2007.07.005","article-title":"Twenty-five years of fiber analysis: what have we learned?","volume":"39","author":"Roggli","year":"2008","journal-title":"Hum Pathol"},{"key":"2020081219330773600_i1543-2165-142-6-730-b12","first-page":"390","article-title":"Analysis of tissue mineral fiber content","author":"Roggli","year":"2014","journal-title":"Pathology of Asbestos-Associated Diseases. 3rd ed"},{"issue":"6","key":"2020081219330773600_i1543-2165-142-6-730-b13","first-page":"614","article-title":"Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: a light and scanning electron microscopic analysis of 18 cases","volume":"8","author":"Srebro","year":"1995","journal-title":"Mod Pathol"},{"issue":"1","key":"2020081219330773600_i1543-2165-142-6-730-b14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5271\/sjweh.3462","article-title":"Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations","volume":"41","author":"Wolff","year":"2015","journal-title":"Scand J Work Environ Health"},{"issue":"2","key":"2020081219330773600_i1543-2165-142-6-730-b15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/01913120252959227","article-title":"Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases","volume":"26","author":"Roggli","year":"2002","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"2020081219330773600_i1543-2165-142-6-730-b16","first-page":"311","article-title":"Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution","volume":"23","author":"Henderson","year":"1997","journal-title":"Scand J Work Environ Health"},{"issue":"8","key":"2020081219330773600_i1543-2165-142-6-730-b17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s10552-009-9357-4","article-title":"Ionizing radiation: a risk factor for mesothelioma","volume":"20","author":"Goodman","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"9","key":"2020081219330773600_i1543-2165-142-6-730-b18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.5858\/arpa.2014-0569-OA","article-title":"Malignant (diffuse) mesothelioma in patients with hematologic malignancies a clinicopathologic study of 45 cases","volume":"139","author":"Li","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"2020081219330773600_i1543-2165-142-6-730-b19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.99.13352399","article-title":"Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort","volume":"13","author":"Metintas","year":"1999","journal-title":"Eur Respir J"},{"issue":"5","key":"2020081219330773600_i1543-2165-142-6-730-b20","first-page":"5722","article-title":"Erionite-associated malignant pleural mesothelioma in Mexico","volume":"9","author":"Oczypok","year":"2016","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"2020081219330773600_i1543-2165-142-6-730-b21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00004836-199706000-00023","article-title":"Peritoneal mesothelioma in recurrent familial peritonitis","volume":"24","author":"Gentiloni","year":"1997","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"2020081219330773600_i1543-2165-142-6-730-b22","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/1097-0142(19850501)55:9<1968::AID-CNCR2820550923>3.0.CO;2-9","article-title":"Malignant mesothelioma secondary to chronic inflammation and old scars: two new cases and review of the literature","volume":"55","author":"Hillerdal","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"2020081219330773600_i1543-2165-142-6-730-b23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jclinpath-2016-203945","article-title":"Malignant peritoneal mesothelioma and Crohn disease","volume":"70","author":"Butnor","year":"2017","journal-title":"J Clin Pathol"},{"issue":"11","key":"2020081219330773600_i1543-2165-142-6-730-b24","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/1097-0142(19821201)50:11<2423::AID-CNCR2820501130>3.0.CO;2-I","article-title":"Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: a study of 25 cases","volume":"50","author":"Roggli","year":"1982","journal-title":"Cancer"},{"issue":"4","key":"2020081219330773600_i1543-2165-142-6-730-b25","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2020081219330773600_i1543-2165-142-6-730-b26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-15-0295","article-title":"Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer","volume":"76","author":"Ohar","year":"2016","journal-title":"Cancer Res"},{"issue":"2","key":"2020081219330773600_i1543-2165-142-6-730-b27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.22129","article-title":"Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases","volume":"53","author":"Pilarski","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"2020081219330773600_i1543-2165-142-6-730-b28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cge.12630","article-title":"Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases","volume":"89","author":"Rai","year":"2016","journal-title":"Clin Genet"},{"issue":"10","key":"2020081219330773600_i1543-2165-142-6-730-b29","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"issue":"6","key":"2020081219330773600_i1543-2165-142-6-730-b30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","author":"Wiesner","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2020081219330773600_i1543-2165-142-6-730-b31","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"issue":"12","key":"2020081219330773600_i1543-2165-142-6-730-b32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"issue":"1","key":"2020081219330773600_i1543-2165-142-6-730-b33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2016.05.034","article-title":"Risk of second primary cancers after malignant mesothelioma and vice versa","volume":"379","author":"Chen","year":"2016","journal-title":"Cancer Lett"},{"key":"2020081219330773600_i1543-2165-142-6-730-b34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajo.2016.02.022","article-title":"Second primary neoplasms in patients with uveal melanoma: a SEER database analysis","volume":"165","author":"Lains","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2020081219330773600_i1543-2165-142-6-730-b35","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaad.2009.07.039","article-title":"Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study","volume":"62","author":"Spanogle","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"2020081219330773600_i1543-2165-142-6-730-b36","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","article-title":"BAP1 is a bona fide tumor suppressor: genetic evidence from mouse models carrying heterozygous germline BAP1 mutations","volume":"76","author":"Kadariya","year":"2016","journal-title":"Cancer Res"},{"issue":"15","key":"2020081219330773600_i1543-2165-142-6-730-b37","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/onc.2015.243","article-title":"Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma","volume":"35","author":"Napolitano","year":"2016","journal-title":"Oncogene"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/142\/6\/730\/1447773\/arpa_2017-0307-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/142\/6\/730\/1447773\/arpa_2017-0307-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:33:58Z","timestamp":1764790438000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/142\/6\/article-p730.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,12]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,3,12]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2017-0307-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,12]]}}}